{"&cites=2198224783170310169&as_sdt=2005&sciodt=0,5&hl=en":[{"title":"Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in …","url":"https://jamanetwork.com/journals/jama/article-abstract/202873","authors":["T Bongartz","T Bongartz AJ Sutton","T Bongartz AJ Sutton MJ Sweeting","T Bongartz AJ Sutton MJ Sweeting I Buchan…"],"year":2006,"numCitations":2615,"pdf":"https://www.ncbi.nlm.nih.gov/books/NBK73416/","citationUrl":"http://scholar.google.com/scholar?cites=9427834457421418162&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:so7K-3xl1oIJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=9427834457421418162&hl=en&as_sdt=2005&sciodt=0,5","publication":"jamanetwork.com","p":1,"exp":1596876814211},{"title":"Adalimumab for maintenance of clinical response and remission in patients with Crohn's disease: the CHARM trial","url":"https://www.sciencedirect.com/science/article/pii/S0016508506025224","authors":["JF Colombel","JF Colombel WJ Sandborn","JF Colombel WJ Sandborn P Rutgeerts","JF Colombel WJ Sandborn P Rutgeerts R Enns…"],"year":2007,"numCitations":2192,"pdf":"https://www.gastrojournal.org/article/S0016-5085(06)02522-4/fulltext","citationUrl":"http://scholar.google.com/scholar?cites=160851794105278993&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:ESIhwdp1OwIJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=160851794105278993&hl=en&as_sdt=2005&sciodt=0,5","publication":"Elsevier"},{"title":"Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind …","url":"https://www.sciencedirect.com/science/article/pii/S0140673604156407","authors":["L Klareskog","L Klareskog D van der Heijde","L Klareskog D van der Heijde JP de Jager","L Klareskog D van der Heijde JP de Jager A Gough…"],"year":2004,"numCitations":2107,"pdf":"http://acpjc.acponline.org/Content/141/2/issue/ACPJC-2004-141-2-042.htm","citationUrl":"http://scholar.google.com/scholar?cites=3788006772024382059&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:a5JJ5Ra0kTQJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=3788006772024382059&hl=en&as_sdt=2005&sciodt=0,5","publication":"Elsevier"},{"title":"Rituximab for rheumatoid arthritis refractory to anti–tumor necrosis factor therapy: results of a multicenter, randomized, double‐blind, placebo‐controlled, phase III trial …","url":"https://onlinelibrary.wiley.com/doi/abs/10.1002/art.22025","authors":["SB Cohen","SB Cohen P Emery","SB Cohen P Emery MW Greenwald…"],"year":2006,"numCitations":1927,"pdf":"https://onlinelibrary.wiley.com/doi/pdf/10.1002/art.22025","citationUrl":"http://scholar.google.com/scholar?cites=1042898541175730086&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:pm-Nm7IeeQ4J:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=1042898541175730086&hl=en&as_sdt=2005&sciodt=0,5","publication":"Wiley Online Library"},{"title":"American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease‐modifying antirheumatic drugs in rheumatoid arthritis","url":"https://onlinelibrary.wiley.com/doi/abs/10.1002/art.23721","authors":["KG Saag","KG Saag GG Teng","KG Saag GG Teng NM Patkar…"],"year":2008,"numCitations":1781,"pdf":"https://onlinelibrary.wiley.com/doi/pdf/10.1002/art.23721","citationUrl":"http://scholar.google.com/scholar?cites=17112596124214357976&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:2O-FMIInfO0J:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=17112596124214357976&hl=en&as_sdt=2005&sciodt=0,5","publication":"Wiley Online Library"},{"title":"Human anti–tumor necrosis factor monoclonal antibody (adalimumab) in Crohn's disease: the CLASSIC-I Trial","url":"https://www.sciencedirect.com/science/article/pii/S0016508505023152","authors":["SB Hanauer","SB Hanauer WJ Sandborn","SB Hanauer WJ Sandborn P Rutgeerts","SB Hanauer WJ Sandborn P Rutgeerts RN Fedorak…"],"year":2006,"numCitations":1720,"pdf":"https://www.gastrojournal.org/article/S0016-5085(05)02315-2/fulltext","citationUrl":"http://scholar.google.com/scholar?cites=17544609849378277378&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:AggD47P5evMJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=17544609849378277378&hl=en&as_sdt=2005&sciodt=0,5","publication":"Elsevier"},{"title":"Tumor necrosis factor antagonist mechanisms of action: a comprehensive review","url":"https://www.sciencedirect.com/science/article/pii/S0163725807002069","authors":["D Tracey","D Tracey L Klareskog","D Tracey L Klareskog EH Sasso","D Tracey L Klareskog EH Sasso JG Salfeld…"],"year":2008,"numCitations":1650,"citationUrl":"http://scholar.google.com/scholar?cites=848955606561904576&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:wNcyT6AYyAsJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=848955606561904576&hl=en&as_sdt=2005&sciodt=0,5","publication":"Elsevier"},{"title":"Protein therapeutics: a summary and pharmacological classification","url":"https://www.nature.com/articles/nrd2399/","authors":["B Leader","B Leader QJ Baca","B Leader QJ Baca DE Golan"],"year":2008,"numCitations":1614,"citationUrl":"http://scholar.google.com/scholar?cites=17662618721822826908&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:nOFpnSU6HvUJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=17662618721822826908&hl=en&as_sdt=2005&sciodt=0,5","publication":"nature.com"},{"title":"Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: a randomized, controlled trial","url":"https://onlinelibrary.wiley.com/doi/abs/10.1002/art.20568","authors":["EW St. Clair","EW St. Clair DMFM Van Der Heijde…"],"year":2004,"numCitations":1425,"pdf":"https://onlinelibrary.wiley.com/doi/pdf/10.1002/art.20568","citationUrl":"http://scholar.google.com/scholar?cites=10013342158858176201&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:yUYv-aOJ9ooJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=10013342158858176201&hl=en&as_sdt=2005&sciodt=0,5","publication":"Wiley Online Library"},{"title":"Natalizumab plus interferon beta-1a for relapsing multiple sclerosis","url":"https://www.nejm.org/doi/full/10.1056/NEJMoa044396","authors":["RA Rudick","RA Rudick WH Stuart","RA Rudick WH Stuart PA Calabresi…"],"year":2006,"numCitations":1409,"pdf":"https://www.nejm.org/doi/full/10.1056/NEJMoa044396","citationUrl":"http://scholar.google.com/scholar?cites=16456544864092184962&as_sdt=2005&sciodt=0,5&hl=en","relatedUrl":"http://scholar.google.com/scholar?q=related:gmF-Bl1kYeQJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=16456544864092184962&hl=en&as_sdt=2005&sciodt=0,5","publication":"Mass Medical Soc"}]}